vs
Bally's Corp（BALY）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Revvity的季度营收约是Bally's Corp的1.0倍（$772.1M vs $746.2M），Revvity净利率更高（12.7% vs -47.3%，领先60.1%），Bally's Corp同比增速更快（28.6% vs 5.9%），过去两年Bally's Corp的营收复合增速更高（9.8% vs 9.0%）
巴利公司是总部位于美国罗德岛州普罗维登斯的博彩、体育投注与互动娱乐企业。目前该公司在美国11个州运营19家赌场，在科罗拉多州拥有一座赛马场，在纽约州拥有一座高尔夫球场，同时在全美14个州开展线上体育投注业务，还通过子公司在澳大利亚两个州运营两处产业。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
BALY vs RVTY — 直观对比
营收规模更大
RVTY
是对方的1.0倍
$746.2M
营收增速更快
BALY
高出22.7%
5.9%
净利率更高
RVTY
高出60.1%
-47.3%
两年增速更快
BALY
近两年复合增速
9.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $746.2M | $772.1M |
| 净利润 | $-353.2M | $98.4M |
| 毛利率 | — | — |
| 营业利润率 | -36.8% | 14.5% |
| 净利率 | -47.3% | 12.7% |
| 营收同比 | 28.6% | 5.9% |
| 净利润同比 | -311.8% | 3.9% |
| 每股收益（稀释后） | $-5.84 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BALYRVTY
| Q4 25 | $746.2M | $772.1M | ||
| Q3 25 | $663.7M | $698.9M | ||
| Q2 25 | $657.5M | $720.3M | ||
| Q1 25 | $368.7M | $664.8M | ||
| Q4 24 | $580.4M | $729.4M | ||
| Q3 24 | $630.0M | $684.0M | ||
| Q2 24 | $621.7M | $691.7M | ||
| Q1 24 | $618.5M | $649.9M |
净利润BALYRVTY
| Q4 25 | $-353.2M | $98.4M | ||
| Q3 25 | $-102.9M | $46.7M | ||
| Q2 25 | $-228.4M | $53.9M | ||
| Q1 25 | $34.5M | $42.2M | ||
| Q4 24 | $-85.8M | $94.6M | ||
| Q3 24 | $-247.9M | $94.4M | ||
| Q2 24 | $-60.2M | $55.4M | ||
| Q1 24 | $-173.9M | $26.0M |
毛利率BALYRVTY
| Q4 25 | — | — | ||
| Q3 25 | — | 53.6% | ||
| Q2 25 | — | 54.5% | ||
| Q1 25 | — | 56.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 55.7% | ||
| Q1 24 | — | 54.6% |
营业利润率BALYRVTY
| Q4 25 | -36.8% | 14.5% | ||
| Q3 25 | 0.1% | 11.7% | ||
| Q2 25 | -0.4% | 12.6% | ||
| Q1 25 | -0.5% | 10.9% | ||
| Q4 24 | -5.6% | 16.3% | ||
| Q3 24 | -25.0% | 14.3% | ||
| Q2 24 | 0.9% | 12.4% | ||
| Q1 24 | -12.0% | 6.8% |
净利率BALYRVTY
| Q4 25 | -47.3% | 12.7% | ||
| Q3 25 | -15.5% | 6.7% | ||
| Q2 25 | -34.7% | 7.5% | ||
| Q1 25 | 9.4% | 6.4% | ||
| Q4 24 | -14.8% | 13.0% | ||
| Q3 24 | -39.3% | 13.8% | ||
| Q2 24 | -9.7% | 8.0% | ||
| Q1 24 | -28.1% | 4.0% |
每股收益（稀释后）BALYRVTY
| Q4 25 | $-5.84 | $0.86 | ||
| Q3 25 | $-1.70 | $0.40 | ||
| Q2 25 | $-3.76 | $0.46 | ||
| Q1 25 | $0.57 | $0.35 | ||
| Q4 24 | $-1.76 | $0.77 | ||
| Q3 24 | $-5.10 | $0.77 | ||
| Q2 24 | $-1.24 | $0.45 | ||
| Q1 24 | $-3.61 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $798.4M | $919.9M |
| 总债务越低越好 | $4.5B | — |
| 股东权益账面价值 | $994.7M | $7.3B |
| 总资产 | $11.2B | $12.2B |
| 负债/权益比越低杠杆越低 | 4.52× | — |
8季度趋势，按日历期对齐
现金及短期投资BALYRVTY
| Q4 25 | $798.4M | $919.9M | ||
| Q3 25 | $160.7M | $931.4M | ||
| Q2 25 | $174.6M | $991.8M | ||
| Q1 25 | $209.7M | $1.1B | ||
| Q4 24 | $171.2M | $1.2B | ||
| Q3 24 | $191.0M | $1.2B | ||
| Q2 24 | $154.7M | $2.0B | ||
| Q1 24 | $169.4M | $1.7B |
总债务BALYRVTY
| Q4 25 | $4.5B | — | ||
| Q3 25 | $3.7B | — | ||
| Q2 25 | $3.6B | — | ||
| Q1 25 | $3.5B | — | ||
| Q4 24 | $3.3B | — | ||
| Q3 24 | $3.7B | — | ||
| Q2 24 | $3.7B | — | ||
| Q1 24 | $3.7B | — |
股东权益BALYRVTY
| Q4 25 | $994.7M | $7.3B | ||
| Q3 25 | $521.5M | $7.4B | ||
| Q2 25 | $630.1M | $7.6B | ||
| Q1 25 | $796.5M | $7.6B | ||
| Q4 24 | $30.9M | $7.7B | ||
| Q3 24 | $233.4M | $7.9B | ||
| Q2 24 | $393.1M | $7.9B | ||
| Q1 24 | $449.4M | $7.8B |
总资产BALYRVTY
| Q4 25 | $11.2B | $12.2B | ||
| Q3 25 | $7.6B | $12.1B | ||
| Q2 25 | $7.8B | $12.4B | ||
| Q1 25 | $7.5B | $12.4B | ||
| Q4 24 | $5.9B | $12.4B | ||
| Q3 24 | $6.4B | $12.8B | ||
| Q2 24 | $6.6B | $13.4B | ||
| Q1 24 | $6.6B | $13.4B |
负债/权益比BALYRVTY
| Q4 25 | 4.52× | — | ||
| Q3 25 | 7.17× | — | ||
| Q2 25 | 5.68× | — | ||
| Q1 25 | 4.33× | — | ||
| Q4 24 | 107.40× | — | ||
| Q3 24 | 15.73× | — | ||
| Q2 24 | 9.34× | — | ||
| Q1 24 | 8.19× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $182.0M |
| 自由现金流经营现金流 - 资本支出 | — | $161.8M |
| 自由现金流率自由现金流/营收 | — | 21.0% |
| 资本支出强度资本支出/营收 | 5.1% | 2.6% |
| 现金转化率经营现金流/净利润 | — | 1.85× |
| 过去12个月自由现金流最近4个季度 | — | $509.4M |
8季度趋势，按日历期对齐
经营现金流BALYRVTY
| Q4 25 | — | $182.0M | ||
| Q3 25 | $-88.6M | $138.5M | ||
| Q2 25 | — | $134.3M | ||
| Q1 25 | $42.0M | $128.2M | ||
| Q4 24 | $37.8M | $174.2M | ||
| Q3 24 | $36.5M | $147.9M | ||
| Q2 24 | $47.6M | $158.6M | ||
| Q1 24 | $-7.9M | $147.6M |
自由现金流BALYRVTY
| Q4 25 | — | $161.8M | ||
| Q3 25 | $-139.3M | $120.0M | ||
| Q2 25 | — | $115.5M | ||
| Q1 25 | $11.5M | $112.2M | ||
| Q4 24 | $-5.9M | $149.8M | ||
| Q3 24 | $-55.8M | $125.6M | ||
| Q2 24 | $11.8M | $136.6M | ||
| Q1 24 | $-35.9M | $129.7M |
自由现金流率BALYRVTY
| Q4 25 | — | 21.0% | ||
| Q3 25 | -21.0% | 17.2% | ||
| Q2 25 | — | 16.0% | ||
| Q1 25 | 3.1% | 16.9% | ||
| Q4 24 | -1.0% | 20.5% | ||
| Q3 24 | -8.9% | 18.4% | ||
| Q2 24 | 1.9% | 19.7% | ||
| Q1 24 | -5.8% | 20.0% |
资本支出强度BALYRVTY
| Q4 25 | 5.1% | 2.6% | ||
| Q3 25 | 7.6% | 2.6% | ||
| Q2 25 | 7.4% | 2.6% | ||
| Q1 25 | 8.3% | 2.4% | ||
| Q4 24 | 7.5% | 3.4% | ||
| Q3 24 | 14.7% | 3.3% | ||
| Q2 24 | 5.7% | 3.2% | ||
| Q1 24 | 4.5% | 2.7% |
现金转化率BALYRVTY
| Q4 25 | — | 1.85× | ||
| Q3 25 | — | 2.97× | ||
| Q2 25 | — | 2.49× | ||
| Q1 25 | 1.22× | 3.03× | ||
| Q4 24 | — | 1.84× | ||
| Q3 24 | — | 1.57× | ||
| Q2 24 | — | 2.87× | ||
| Q1 24 | — | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BALY
| Casinos Resorts | $366.2M | 49% |
| Non Casino | $172.7M | 23% |
| Food And Beverage | $74.6M | 10% |
| Hotel | $69.9M | 9% |
| North America Interactive | $62.3M | 8% |
| Loyalty Programs | $6.7M | 1% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
